Atlas Trials

Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations

Clinical trial NCT06955325 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06955325
Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2025-05-01
Primary completion
2030-12-01
Enrollment
270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.